Delayed Sleep Phase Syndrome
12
3
3
5
Key Insights
Highlights
Success Rate
71% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
16.7%
2 terminated out of 12 trials
71.4%
-15.1% vs benchmark
42%
5 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Experimental Manipulation of Sleep and Circadian Rhythms and the Role Played on Reward Function in Teens
Lemborexant in Delayed Sleep Phase Syndrome
Biomarkers for Circadian Timing in Healthy Adults
Breath Biomarkers for Sleep Loss and Circadian Timing
Lemborexant in Delayed Sleep Phase Syndrome
Validation of Circadian Biomarkers in Patients With Sleep Disorders
Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder
The Clinical Utility of Measuring the Circadian Clock in Treatment of Delayed Sleep-Wake Phase Disorder
Are Patients Suffering From DSPS Show Compromising in Everyday Functions and Abilities Before Handling the Disorder?
Randomized Controlled Trial on the Treatment Effects of Melatonin and Light Therapy on Delayed Sleep Phase Syndrome
Does Cognitive Behaviour Therapy (CBT) Improve the Effect of Light Therapy
Synchronization and Desynchronization Between Circadian Rhythms in Patients With Delayed Sleep Phase Syndrome (DSPS)